carboplatin,etoposide,atezolizumab,tiragolumab
roche
['skyscraper-02', 'skyscraper-01']
interesting slide from c rudin on how alpha was apportioned in skyscraper-02. (he didn't give a stat analysis plan for skyscraper-01 ) #asco22 
Journalist at Evaluate Vantage. Proudly blocked by @JohnCendpts. Interested in: oncology, immunology. Not interested in: what stock you bought today.